Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: Pragmatic, multicentre, randomised controlled trial

The Lancet

Volumn 385, Issue 9970, 2015, Pages 775-784

  Stewart, Simon ^a,b   Ball, Jocasta ^a   Horowitz, John D ^c   Marwick, Thomas H ^d   Mahadevan, Gnanadevan ^c   Wong, Chiew ^e   Abhayaratna, Walter P ^f   Chan, Yih K ^a,b   Esterman, Adrian ^g   Thompson, David R ^a   Scuffham, Paul A ^h   Carrington, Melinda J ^a,b  

^a AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

^e WESTERN HOSPITAL   (Australia)

^f AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^g UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^h GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIURETIC AGENT; WARFARIN;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; AUSTRALIA; BLEEDING; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOLTER MONITORING; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; RANDOMIZED CONTROLLED TRIAL; STANDARD; SURVIVAL TIME; ATRIAL FIBRILLATION; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; HOME CARE; KAPLAN MEIER METHOD; MORTALITY; NURSING; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PROCEDURES; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK FACTOR; SECONDARY PREVENTION; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; CHRONIC DISEASE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HOME CARE SERVICES; HUMANS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; MALE; PATIENT CARE TEAM; PATIENT READMISSION; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 84925581462     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)61992-9     Document Type: Article

References (31)

1. J Ball, MJ Carrington, JJV McMurray, S Stewart Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century Int J Cardiol 167 2013 1807 1824
2. NJ Patel, A Deshmukh, S Pant et al. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning Circulation 129 2014 2371 2379
3. DG Wyse, AL Waldo, JP DiMarco for the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
4. SJ Connolly, MD Ezekowitz, S Yusuf the RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
5. MJ Carrington, J Ball, JD Horowitz et al. Navigating the fine line between benefit and risk in chronic atrial fibrillation: rational and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY) Int J Cardiol 166 2013 359 365
6. C Feltner, CD Jones, CW Cené et al. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis Ann Intern Med 160 2014 774 784
7. S Inglis, S McLennan, A Dawson et al. A new solution for an old problem? Effects of a nurse-led, multidisciplinary, home-based intervention on readmission and mortality in patients with chronic atrial fibrillation J Cardiovasc Nurs 19 2004 118 127
8. JML Hendriks, R de Wit, HJGM Crijns et al. Nurse-led care vs usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs routine clinical care in ambulatory patients with atrial fibrillation Eur Heart J 33 2012 2692 2699
9. M Zwarenstein, S Treweek, JJ Gagnier et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement BMJ 337 2008 a2390
10. AJ Camm, P Kirchhof, GYH Lip et al. Guidelines for the management of atrial fibrillation Eur Heart J 31 2010 2369 2429
11. HM Krumholz, PM Currie, B Riegel et al. A taxonomy for disease management: a scientific statement from the American Heart Association disease management taxonomy writing group Circulation 114 2006 1432 1445
12. MJ Carrington, S Kok, K Jansen, S Stewart The Green, Amber, Red Delineation of Risk and Need (GARDIAN) management system: a pragmatic approach to optimizing heart health from primary prevention to chronic disease management Eur J Cardiovasc Nurs 12 2013 337 345
13. JE Brazier, J Roberts The estimation of a preference-based measure of health from the SF-12 Med Care 42 2004 851 859
14. R Rabin, F de Charro EQ-5D: a measure of health status from the EuroQoL Group Ann Med 33 2001 337 343
15. CL Craig, AL Marshall, M Sjostrom et al. International physical activity questionnaire: 12-country reliability and validity Med Sci Sports Exerc 35 2003 1381 1395
16. B Arroll, N Khin, N Kerse Screening for depression in primary care with two verbally asked questions: cross sectional study BMJ 327 2003 1144 1146
17. LS Radloff The CES-D scale: a self-report depression scale for research in the general population Appl Psychol Meas 1 1977 385 401
18. ZS Nasreddine, NA Phillips, V Bedirian et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment J Am Geriatr Soc 53 2005 695 699
19. SH Hohnloser, HJGM Crijns, M van Eickels et al. Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
20. GY Lip, R Nieuwlaat, R Pisters, DA Lane, HJ Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation Chest 137 2010 263 272
21. V Sundararajan, T Henderson, C Perry, A Muggivan, H Quan, WA Ghali New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality J Clin Epidemiol 57 2004 1288 1294
22. J Ball, MJ Carrington, DR Thompson, JD Horowitz, S Stewart on behalf of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY) investigators Post-discharge electrocardiogram Holter monitoring in recently hospitalised individuals with chronic atrial fibrillation to enhance therapeutic monitoring and identify potentially predictive phenotypes Eur J Cardiovasc Nurs 2014 published online Aug 14. http://dx.doi.org/10.1177/1474515114547650
23. K Page, TH Marwick, R Lee et al. A systematic approach to chronic heart failure care: a consensus statement Med J Aust 201 2014 146 150
24. S Stewart, MJ Carrington, JD Horowitz et al. Prolonged impact of home versus clinic-based management of chronic heart failure: extended follow-up of a pragmatic, multicentre randomized trial cohort Int J Cardiol 174 2014 600 610
25. J Ball, MJ Carrington, S Stewart Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management? Heart 99 2013 542 547
26. S Pearson, SC Inglis, SN McLennan et al. Prolonged effects of a home-based intervention in patients with chronic illness Arch Intern Med 166 2006 645 650
27. MJ Carrington, YK Chan, A Calderone et al. A multicenter, randomized trial of a nurse-led, home-based intervention for optimal secondary cardiac prevention suggests some benefits for men but not for women: the Young at Heart study Circ Cardiovasc Qual Outcomes 6 2013 379 389
28. M Ledwidge, J Gallagher, C Conlon et al. Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial JAMA 310 2013 66 74
29. CA Ariti, JGF Cleland, SJ Pocock et al. Days alive and out of hospital and the patient journey in patients with heart failure: insights from the candesartan in heart failure, assessment of reduction in mortality and morbidity (CHARM) program Am Heart J 162 2011 900 906
30. CB Granger, JH Alexander, JJV McMurray et al. Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
31. S Stewart, N Murphy, A Walker, A McGuire, JJV McMurray Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK Heart 90 2004 286 292